164605 | Aminopeptidase N (CD13), Human Serum

Aminopeptidase N (CD13), Human Serum MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: APN/CD13, Aminopeptidase N

164605
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
—
Request Pricing
—
Limited AvailabilityLimited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      View Pricing & Availability
      Click To Print This Page

      Overview

      Replacement Information

      Key Spec Table

      Pricing & Availability

      Catalogue NumberAvailability Packaging Qty/Pack Price Quantity
      US1164605-10UG
      Retrieving availability...
      —
      Limited AvailabilityLimited Availability
      In Stock 
      Discontinued
      Limited Quantities Available
      Availability to be confirmed
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service

          		Plastic ampoule 10 μg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          —
          Request Pricing
          		 —
          Description
          OverviewNative aminopeptidase N purified from human serum. Aminopeptidase N is a single-chain, integral membrane protease with broad specificity that functions to remove N-terminal amino acids from peptides. It also acts as a receptor for coronavirus and is known to play a role in angiogenesis, HIV entry, and in degradation of extracellular matrix as a result of tumor invasion.
          Catalogue Number164605
          Brand Family Calbiochem®
          SynonymsAPN/CD13, Aminopeptidase N
          References
          ReferencesBhagwat, S.V., et al. 2003. Blood 101, 1818.
          Kawai, M., et al. 2001. Clin. Chem. 47, 223.
          Watanabe, Y., et al. 1998. Mol. Genet. Metab. 63, 289.
          Pulido-Cejudo, G., et al. 1997. Antiviral Res. 36, 167.
          Hansen, A.S., et al. 1993. Eur. J. Immunol. 23, 2358.
          Saiki, I., et al. 1993. Int. J. Cancer 54,137.
          Shipp, M.A. and Look, A.T. 1993. Blood 82, 1052.
          Yeager, C.L., et al. 1992. Nature 357, 420.
          Product Information
          Unit of DefinitionOne unit is defined as the amount of enzyme that will hydrolyze 1.0 µmol L-leucine-p-nitroanilide) per min at 37°C, pH 7.2.
          EC number3.4.11.2
          FormLiquid
          FormulationIn 150 mM NaCl, 50 mM Tris-HCl, 1 mM CaCl₂, pH 8.0.
          Applications
          Biological Information
          Purity≥92% by SDS-PAGE
          SourcePrepared from human serum that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
          Specific Activity≥450 mU/mg protein
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Dry Ice Only
          Toxicity Standard Handling
          Storage ≤ -70°C
          Avoid freeze/thaw Avoid freeze/thaw
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Certificates of Analysis

          TitleLot Number
          164605

          References

          Reference overview
          Bhagwat, S.V., et al. 2003. Blood 101, 1818.
          Kawai, M., et al. 2001. Clin. Chem. 47, 223.
          Watanabe, Y., et al. 1998. Mol. Genet. Metab. 63, 289.
          Pulido-Cejudo, G., et al. 1997. Antiviral Res. 36, 167.
          Hansen, A.S., et al. 1993. Eur. J. Immunol. 23, 2358.
          Saiki, I., et al. 1993. Int. J. Cancer 54,137.
          Shipp, M.A. and Look, A.T. 1993. Blood 82, 1052.
          Yeager, C.L., et al. 1992. Nature 357, 420.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision06-September-2007 RFH
          SynonymsAPN/CD13, Aminopeptidase N
          DescriptionNative aminopeptidase N purified from human serum. Aminopeptidase N is a single-chain, integral membrane protease with broad specificity that functions to remove N-terminal amino acids from peptides. It also acts as a receptor for coronavirus and is known to play a role in angiogenesis, HIV entry, and in degradation of extracellular matrix as a result of tumor invasion. Activity is inhibited by amastatin, actinonin, and bestatin (Cat. No. 200484) (~150 µM).
          FormLiquid
          FormulationIn 150 mM NaCl, 50 mM Tris-HCl, 1 mM CaCl₂, pH 8.0.
          SourcePrepared from human serum that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
          EC number3.4.11.2
          Purity≥92% by SDS-PAGE
          Specific activity≥450 mU/mg protein
          Unit definitionOne unit is defined as the amount of enzyme that will hydrolyze 1.0 µmol L-leucine-p-nitroanilide) per min at 37°C, pH 7.2.
          Storage ≤ -70°C
          Avoid freeze/thaw
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
          Toxicity Standard Handling
          ReferencesBhagwat, S.V., et al. 2003. Blood 101, 1818.
          Kawai, M., et al. 2001. Clin. Chem. 47, 223.
          Watanabe, Y., et al. 1998. Mol. Genet. Metab. 63, 289.
          Pulido-Cejudo, G., et al. 1997. Antiviral Res. 36, 167.
          Hansen, A.S., et al. 1993. Eur. J. Immunol. 23, 2358.
          Saiki, I., et al. 1993. Int. J. Cancer 54,137.
          Shipp, M.A. and Look, A.T. 1993. Blood 82, 1052.
          Yeager, C.L., et al. 1992. Nature 357, 420.